FindTrial
Sign In

The effect of dexmedetomidine on evoked potential monitoring of cervical decompression fusion surgery with total intravenous anesthesia

The effect of dexmedetomidine on evoked potential monitoring of cervical decompression fusion surgery with total intravenous anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072621
Enrollment
Unknown
Registered
2023-06-19
Start date
2019-11-01
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylosis

Interventions

C group:NS
D group:Dextmedetomidine

Sponsors

General Hospital of Ningxia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients with cervical spondylosis, patients undergoing anterior cervical spine decompression fusion surgery; (2) ASA grade I~III; (3) Age 18~65 years old, gender is not limited; (4) Body mass index 18.5~23.9kg/m2.

Exclusion criteria

Exclusion criteria: (1) Patients with craniocerebral trauma; (2) patients with diabetes; (3) Patients with preoperative ECG showing atrioventricular block and/or sinus bradycardia; (4) Patients with preoperative anemia; (5) Patients who are allergic to dexmedetomidine.

Design outcomes

Primary

MeasureTime frame
Amplitude;latency;—

Secondary

MeasureTime frame
BIS;blood pressure;HR;—

Countries

China

Contacts

Public Contactminhongxing

Department of Anesthesiology, General Hospital of Ningxia Medical University

1305801763@qq.com+86 137 0951 8969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026